Replimune
REPL
#4939
Rank
โ‚ฌ1.64 B
Marketcap
17,38ย โ‚ฌ
Share price
-0.83%
Change (1 day)
117.62%
Change (1 year)

EPS for Replimune (REPL)

EPS in 2026 (TTM): -2,53ย โ‚ฌ

According to Replimune 's latest financial reports the company's current EPS (TTM) is -2,67ย โ‚ฌ. a decrease over its 2025 EPS that were of -2,80ย โ‚ฌ.

EPS history for Replimune from 2017 to 2026

Annual EPS

Year EPS Change
2026-3,08ย โ‚ฌ10.1%
2025-2,80ย โ‚ฌ-5.25%
2024-2,95ย โ‚ฌ8.36%
2023-2,73ย โ‚ฌ32.3%
2022-2,06ย โ‚ฌ29.14%
2021-1,60ย โ‚ฌ13.64%
2020-1,40ย โ‚ฌ15.79%
2019-1,21ย โ‚ฌ45.18%
2018-0,84ย โ‚ฌ155.74%
2017-0,33ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-53.92%๐Ÿ‡บ๐Ÿ‡ธ USA